by Tom Ruginis | Apr 25, 2018 | Business |
One of the key values Perlara was founded on is transparency, and a commitment to open business practices. To that end, and to help other entrepreneurs get an idea of what it’s like to launch and run a biotech start-up, we’ve been posting regular updates about...
by Tom Ruginis | Dec 28, 2017 | Start-ups |
When we last checked in a year ago, Perlara had just achieved three critical milestones: a product (PerlQuest), a validating Pharma deal, and first revenue – a small check, but revenue nonetheless. Over the course of 2017, we transitioned from startup with a...
by Tom Ruginis | Dec 13, 2016 | Start-ups |
As 2016 draws to a close, we look back on two and half years of Perlara spending. Let’s begin with burn rate. This figure shows our monthly burn since first cash inflows in April 2014: In 2014, we completed model validation and assay development for our lead discovery...
by Tom Ruginis | Feb 19, 2016 | Start-ups |
As a Public Benefit Corporation, transparency is a common thread tying our missions together. From the outset we decided to share PLab financial data. You can find previous disclosures from H1 2015 (here) and Q3 2015 (here). Below are details about our burn rate from...
by Tom Ruginis | Nov 10, 2015 | Start-ups |
Back in 2014 when PLab was first funded, one of the first hires wasn’t an employee, but a contractor….HappiLabs. Bootstrapping their way into existence, HappiLabs provides a service called the Virtual Lab Manager, specializing in purchasing lab supplies...